Atea Pharmaceuticals Inc (AVIR) returns
Atea Pharmaceuticals returns over 5 years
$1,000 invested in Atea Pharmaceuticals five years ago was worth $353.09 at the close on October 30, 2026, with dividends reinvested: an average return of -18.8% a year. The same $1,000 in the S&P 500 (SPY) became $1,760.
Total return by period
| Period | Total return | A year, on average | $1,000 became | S&P 500 (SPY) |
|---|---|---|---|---|
| 1 month | -21.1% | — | $788.87 | -0.9% |
| 3 months | -13.3% | — | $867.09 | +2.1% |
| Year to date | +15.1% | — | $1,151 | +11.7% |
| 1 year | +25.7% | — | $1,257 | +12.4% |
| 3 years | +32.6% | +9.9% | $1,326 | +88.5% |
| 5 years | -64.7% | -18.8% | $353.09 | +76.0% |
Atea Pharmaceuticals return by calendar year
| Year | AVIR | S&P 500 (SPY) | Difference |
|---|---|---|---|
| 2026 to date | +15.1% | +11.7% | +3.4% |
| 2025 | +6.6% | +17.7% | -11.1% |
| 2024 | +9.8% | +24.9% | -15.0% |
| 2023 | -36.6% | +26.2% | -62.8% |
| 2022 | -46.2% | -18.2% | -28.0% |
| 2021 | -78.6% | +28.7% | -107.3% |
Past returns do not predict future returns. Returns are computed from our daily closes, adjusted for splits and with dividends reinvested on their ex-dates; taxes and trading costs are left out.
See also:
No forecast, no recommendation. This page describes Atea Pharmaceuticals Inc from published data; it is not advice to buy, sell or hold any security.
Figures as of the close on Oct 30, 2026 unless a row says otherwise. Prices are split adjusted; returns include dividends reinvested. Data may be delayed. See the disclaimer and how TrendArc works.